List of works - Nathaniel G. Milton

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.

scientific article

Cholesterol in Alzheimer's disease and other amyloidogenic disorders.

scientific article published on January 2010

Corticotrophin-releasing factor-41 in the human and rat-utility of a highly sensitive enzyme amplified immunometric assay

scientific article published on 01 December 1990

Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro

scientific article published on 01 September 1989

Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro

scientific article published on 01 September 1989

Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.

scientific article published on 20 July 2012

Human islet amyloid polypeptide fibril binding to catalase: a transmission electron microscopy and microplate study.

scientific article published on 18 May 2010

Immunocytochemical staining of endogenous nuclear proteins with the HIS-1 anti-poly-histidine monoclonal antibody: a potential source of error in His-tagged protein detection.

scientific article published on 14 May 2014

Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient

scientific article published on 16 May 2013

Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer's amyloid-beta peptide.

scientific article published in December 2001

Introduction and Technical Survey: Protein Aggregation and Fibrillogenesis ⬇️

scientific article published on January 1, 2012

Kisspeptin Prevention of Amyloid-β Peptide Neurotoxicityin Vitro ⬇️

scientific article published on May 30, 2012

Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.

scientific article published on 16 July 2009

Production and utilization of monoclonal antibodies to human/rat corticotrophin-releasing factor-41

scientific article published on 01 October 1990

Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment.

scientific article published on January 2004

The Role of Neurotransmitters in Protection against Amyloid- β Toxicity by KiSS-1 Overexpression in SH-SY5Y Neurons

scientific article

The amyloid-beta peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity.

scientific article

The effects of rat corticotrophin-releasing factor-41 Peptide fragments on bioassay and immunoassay determination of corticotrophin-releasing factor-41 levels

scientific article published on 01 December 1990

The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA

scientific article published on 06 June 2019

The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy.

scientific article published in March 1993

The neuronal nicotinic acetylcholine receptor alpha 2 subunit gene promoter is activated by the Brn-3b POU family transcription factor and not by Brn-3a or Brn-3c.

scientific article

List of works by Nathaniel G. Milton

Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.

Cholesterol in Alzheimer's disease and other amyloidogenic disorders.

Corticotrophin-releasing factor-41 in the human and rat-utility of a highly sensitive enzyme amplified immunometric assay

Effect of acetylcholine and 5-hydroxytryptamine on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro

Effect of noradrenaline and gamma-aminobutyric acid on the secretion of corticotrophin-releasing factor-41 and arginine vasopressin from the rat hypothalamus in vitro

Fibril formation and toxicity of the non-amyloidogenic rat amylin peptide.

Human islet amyloid polypeptide fibril binding to catalase: a transmission electron microscopy and microplate study.

Immunocytochemical staining of endogenous nuclear proteins with the HIS-1 anti-poly-histidine monoclonal antibody: a potential source of error in His-tagged protein detection.

Immunolocalization of Kisspeptin Associated with Amyloid-β Deposits in the Pons of an Alzheimer's Disease Patient

Inhibition of catalase activity with 3-amino-triazole enhances the cytotoxicity of the Alzheimer's amyloid-beta peptide.

Introduction and Technical Survey: Protein Aggregation and Fibrillogenesis ⬇️

Kisspeptin Prevention of Amyloid-β Peptide Neurotoxicityin Vitro ⬇️

Polymorphism of amyloid-beta fibrils and its effects on human erythrocyte catalase binding.

Production and utilization of monoclonal antibodies to human/rat corticotrophin-releasing factor-41

Role of hydrogen peroxide in the aetiology of Alzheimer's disease: implications for treatment.

The Role of Neurotransmitters in Protection against Amyloid- β Toxicity by KiSS-1 Overexpression in SH-SY5Y Neurons

The amyloid-beta peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity.

The effects of rat corticotrophin-releasing factor-41 Peptide fragments on bioassay and immunoassay determination of corticotrophin-releasing factor-41 levels

The formyl peptide receptor agonist FPRa14 induces differentiation of Neuro2a mouse neuroblastoma cells into multiple distinct morphologies which can be specifically inhibited with FPR antagonists and FPR knockdown using siRNA

The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy.

The neuronal nicotinic acetylcholine receptor alpha 2 subunit gene promoter is activated by the Brn-3b POU family transcription factor and not by Brn-3a or Brn-3c.